Form 8-K - Current report:
SEC Accession No. 0001104659-19-062239
Filing Date
2019-11-12
Accepted
2019-11-12 10:01:21
Documents
3
Period of Report
2019-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1922249-1_8k.htm 8-K 20581
2 EXHIBIT 99.1 tm1922249-1_ex991.htm EX-99.1 98018
3 GRAPHIC image_002.jpg GRAPHIC 4218
  Complete submission text file 0001104659-19-062239.txt   125796
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20713 | Film No.: 191206807
SIC: 2836 Biological Products, (No Diagnostic Substances)